Renalytix to Present at the 41st Annual Canaccord Genuity Global Growth Conference

Rhea-AI Summary

Renalytix (NASDAQ: RNLX) will present at the 41st Annual Canaccord Genuity Virtual Global Growth Conference on August 11, 2021, at 2:30 PM EDT. The presentation will be accessible via a live and archived webcast on the company's website in the investors section.

Renalytix focuses on developing AI-enabled clinical diagnostics for kidney disease, aiming to enhance diagnosis, clinical care, and drug discovery related to one of the most prevalent chronic health issues.

NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (LSE: RENX) (NASDAQ: RNLX) (“Renalytix” or the “Company”) today announced the company will be presenting at the upcoming 41^st Annual Canaccord Genuity Virtual Global Growth Conference.

Renalytix’s management is scheduled to present at the Canaccord Genuity Global Growth Conference on Wednesday, August 11 at 2:30pm EDT. Interested parties may access a live and archived webcast of the presentations on the “Investors” section of the company website at investors.renalytix.com.

For further information, please contact:

UK Investor Contact:

Walbrook PR Limited	Tel: 020 7933 8780 or renalytix@walbrookpr.com
Paul McManus / Lianne Cawthorne		Mob: 07980 541 893 / 07584 391 303

US Investor Contact:

Gilmartin Group	investors@renalytix.com
Carrie Mendivil / Mary Kate McDonough		415-937-5405

About Renalytix
Renalytix is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. Renalytix's products are being designed to make significant improvements in kidney disease diagnosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit www.renalytix.com.

FAQ

When is Renalytix presenting at the Canaccord Genuity Global Growth Conference?

Renalytix will present on August 11, 2021, at 2:30 PM EDT.

How can I access the Renalytix presentation from the conference?

You can access the presentation live and in archive format on the investors section of the Renalytix website.

What is the focus of Renalytix in the healthcare sector?

Renalytix focuses on AI-enabled diagnostics for kidney disease, improving diagnosis, clinical care, and drug discovery.

Where can I find more information about Renalytix?

More information is available on Renalytix's official website at www.renalytix.com.